M7824 (MSB0011359C)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M7824 (MSB0011359C), covering 2021-06-16 to 2021-06-16. Get the full timeline:
Most recent: Clinical Trial Update: M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas [Phase 1, Phase 2]